Skip to main content

COVID 19 Updates from RheumNow

Social

Racial/ethnic minorities with rheumatic Dz(RD) & COVID had increased odds of hospitalization & ventilatory support. 1,324 pts w/ RD+COVID, 36% hospitalized, 6% died. Compared to whites- Blacks Latinos & Asians had higher risk of hospital (OR=2.7, 1.7, 2.7) https://t.co/OGmarAfzLM

Dr. John Cush @RheumNow ( View Tweet )

4 years ago
Cohort study (n 186) from NYC shows that patients with COVID and autoimmune disease were not at an increased risk for a ICU admission, intubation, or death (adjOR 0.79, 95%CI 0.37-1.67). AI pts had more comorbidities (26% vs. 13%), immunosuppressives https://t.co/TMCcKbns0f

Dr. John Cush @RheumNow ( View Tweet )

4 years ago
RheumNow Podcast is UP! ACR 20 is Coming to Town - news on melanoma, COVID biologics & autoantibodies, Hepatitis & JAKs, Safety of nintedinib, upcoming ACR2020. Watch it here> https://t.co/np5aFCo9FB or listen on Apple> https://t.co/FHJv01AAbC or Android> https://t.co/qxuBmiNxU0

Dr. John Cush @RheumNow ( View Tweet )

4 years ago
QD104 - You Are So Not Disabled QD Clinic - Lessons from the clinic Grappling with Disability Letter Requests Features Dr. Jack Cush https://t.co/Vg5i9rHyKN

Dr. John Cush @RheumNow ( View Tweet )

4 years ago
Autoantibodies can be found in COVID-19 ptas (including ANA, RF, -RNP centromere and antibobides against phospholipids (3/52), prothrombin (2/52), and c-ANCA (2/52)) (THIS IS A PREPRINT) https://t.co/kN6hVMiNt3 https://t.co/4yNJJhOxXP

Dr. John Cush @RheumNow ( View Tweet )

4 years 1 month ago
ACTIV-1 run by the ⁦@NIH⁩ will test rheum drugs infliximab and abatacept in COVID-19. This is great news. https://t.co/IITzGTuxEC

Dr Philip Robinson @philipcrobinson ( View Tweet )

4 years 1 month ago
Randomized trial of 491 probable nonhospitalized COVID-19 pts shows that HCQ (given 800 mg, followed by 600 mg in 6 -8 hrs, then 600 mg qd x 4d) or placebo shows no reduction in symptom severity in outpatients with early, mild COVID-19.https://t.co/yVWGRr6jfr

Dr. John Cush @RheumNow ( View Tweet )

4 years 1 month ago
FDA approved its 1st drug to treat COVID-19 - the antiviral drug Veklury (remdesivir) for for acute care treatment of COVID-19 requiring hospitalization. Approval based on 3 clinical trials showing clinical improvement, but no change in mortality rates. https://t.co/IrA7oKMuGq

Dr. John Cush @RheumNow ( View Tweet )

4 years 1 month ago
Study from NY shows that Death rates from COVID-19 have dropped (in hospitalized pts) from a high of 27% down to 3%. Partly because a younger, healthier are now getting infected, arriving @ hospital w/ less-severe Sxs. Also improved COVID medical care https://t.co/8aFuVHUDjY

Dr. John Cush @RheumNow ( View Tweet )

4 years 1 month ago
#LTF Listen to Fauci

Dr. John Cush @RheumNow ( View Tweet )

4 years 1 month ago
×